Literature DB >> 18174968

Drug-induced optic neuropathies.

Michael J Lloyd1, Frederick W Fraunfelder.   

Abstract

The term optic neuropathy is used to describe optic nerve damage caused by any of four main etiologies: ischemic, hereditary, nutritional and toxic. Ischemic and hereditary optic neuropathies produce profound and often irreversible vision loss. Proper diagnosis of nutritional or toxic optic neuropathies provides the opportunity for potential treatment and hope of restored visual function. Toxic optic neuropathy may occur from exposure or ingestion of non-medicinal compounds such as methanol, carbon monoxide, toluene and ethylene glycol or may be the result of an adverse drug reaction. Many drugs have been associated with optic nerve disease (Table I). This article describes agents on which the most data is available, and which most frequently cause adverse reactions. Amiodarone, ethambutol, linezolid and sildenafil are commonly prescribed medications. Since most practitioners frequently encounter patients taking one or more of these drugs, awareness of optic neuropathy risk is essential for timely referral and accurate diagnosis. The most important aspect of treatment is identification of the offending agent and prompt drug withdrawal. Where there is consensus, we will present guidelines on screening for and managing the various drug-induced optic neuropathies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18174968     DOI: 10.1358/dot.2007.43.11.1157621

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  4 in total

1.  Dronedarone in patients with atrial fibrillation.

Authors:  N M S de Groot; C J Kirchhof; I C van Gelder; J G Meeder; A H M M Balk; A A Wilde; M L Simoons
Journal:  Neth Heart J       Date:  2010-08       Impact factor: 2.380

2.  Safety and quality assessment of 175 illegal sexual enhancement products seized in red-light districts in Singapore.

Authors:  Min-Yong Low; Yun Zeng; Lin Li; Xiao-Wei Ge; Ruth Lee; Bosco-Chen Bloodworth; Hwee-Ling Koh
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 3.  Volatile substance misuse: an updated review of toxicity and treatment.

Authors:  Jonathan B Ford; Mark E Sutter; Kelly P Owen; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

4.  What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?

Authors:  Graham E Ewing
Journal:  N Am J Med Sci       Date:  2009-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.